Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Telit announces deviceWISE IoT platform interoperability with the IBM IoT platform July 13, 2018 Banks weigh tier-I bond sales to strengthen capital base October 12, 2017 India said to seek job creation pledge from Apple in lieu of tax breaks June 6, 2017